COMMUNIQUÉS West-GlobeNewswire

Biocartis Group NV: Disclosure of a transparency notification
29/05/2018
PRESS RELEASE: REGULATED INFORMATION 29 May 2018, 07:00 CEST Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Mechelen, Belgium, [...]
Orphazyme Capital Markets Day 2018 – from Biology to Bedside
29/05/2018
Orphazyme A/S Company announcement No. 06/2018 Copenhagen, May 29, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, announces that a Capital [...]
Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc.
29/05/2018
Creates Premier Women’s Health Business Unit in High Growth Genetic Testing Market SALT LAKE CITY, May 28, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and [...]
Nova Leap Health Corp. Reports First Quarter 2018 Financial Results and Provides Corporate Update
28/05/2018
HALIFAX, Nova Scotia, May 28, 2018 (GLOBE NEWSWIRE) -- NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES NOVA LEAP HEALTH CORP. (TSXV:NLH) (“Nova Leap” or “the Company”), a company [...]
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
28/05/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - May 28, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Cannabis Wheaton Income Corp. Streaming Partner FSD Pharma Inc. to Commence Trading on CSE Under Symbol “HUGE”
28/05/2018
VANCOUVER, British Columbia, May 28, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) (" Cannabis Wheaton " or the " Company ") is pleased to announce that its previously announced streaming partner [...]
AB Science provides update on EU marketing authorization application for masitinib in the treatment of amyotrophic lateral sclerosis
28/05/2018
Paris, May 28, 2018, 6.15pm AB Science provides update on EU marketing authorization application for masitinib in the treatment of amyotrophic lateral sclerosis AB Science SA (NYSE Euronext - FR0010557264 - AB), a [...]
AB Science fait le point sur la demande d'autorisation de mise sur le marché du masitinib dans le traitement de la sclérose latérale amyotrophique
28/05/2018
Paris, 28 mai 2018, 18h15 AB Science fait le point sur la demande d'autorisation de mise sur le marché du masitinib dans le traitement de la sclérose latérale amyotrophique AB Science SA (NYSE Euronext - FR0010557264 - [...]
Ossur Hf :Transactions in relation to share buyback program
28/05/2018
Announcement no. 37/2018 Reykjavik, 28 May 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
NÉOVACS : COMPTE-RENDU ASSEMBLÉE GÉNÉRALE ANNUELLE 2018
28/05/2018
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE COMPTE-RENDU ASSEMBL É E G É N É RALE ANNUELLE 2018 ACTIVATION DE LA DERNI È RE TRANCHE DE LA LIGNE DE FINANCEMENT EN FONDS PROPRES EXISTANTE, [...]
Share buy-back week 21/2018
28/05/2018
Announcement 28 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
Novartis International AG: Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto®
28/05/2018
Overall summary score was also significantly higher for Entresto patients than for patients not taking Entresto, as measured by the 12-item Kansas City Cardiomyopathy Questionnaire (KCCQ-12)[1] These improvements were [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2018
28/05/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 28, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces financial [...]
Novo Nordisk A/S - Share repurchase programme
28/05/2018
Bagsværd, Denmark, 28 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia
28/05/2018
Company Announcement - No. 16/2018 Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia Last patient visit concluded in the multinational [...]
Mandatory notification of trade
28/05/2018
Reference is made to the announcement today from Vistin Pharma ASA ("Vistin Pharma") regarding the final result of the subsequent repair issue. Vegard Heggem, VP Operations, has been allocated 10,000 new shares at a [...]
Transactions under Novozymes’ stock buyback program
28/05/2018
Please read the full announcement in the attached PDF Attachment 2018_36_Stock_Buybackprogram_EN
Announcement by Heirs of Late Valerijs Maligins
28/05/2018
Announcement by Heirs of Late Valerijs Maligins JSC Olainfarm hereby informs that it has received the folowing announcement from heirs of Valerijs Maligins. Mutually Acceptable Agreement is Reached About Distribution of [...]
Solon Eiendom ASA : Primary insider notification
28/05/2018
(Oslo, Norway, May 25, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Dukat AS) has today bought 30.000 shares in Solon Eiendom ASA at a price of NOK 28.7105. Following this [...]

Pages